MedicaidPrior AuthLow impact
Kimmtrak (tebentafusp-tebn) (New)
Humana·LA · Oncology·Medicaid
Effective date
Dec 1, 2025
We identified it
Jun 24, 2026
Summary
New prior authorization policy for Kimmtrak (tebentafusp-tebn) for Louisiana Medicaid patients with metastatic uveal melanoma. Requires specific HLA-A*02:01-positive disease documentation and must be used as monotherapy.
Action Required
By December 1, 2025: Billing team must update prior authorization procedures for Kimmtrak (tebentafusp-tebn) for Louisiana Medicaid patients. Ensure documentation includes unresectable/metastatic uveal melanoma diagnosis, HLA-A*02:01-positive assay results, and monotherapy use confirmation before submitting claims. Claims without proper prior authorization will be denied.